Recro Pharma Inc (NASDAQ:REPH)

8.30
Delayed Data
As of Feb 16
 -0.40 / -4.60%
Today’s Change
5.81
Today|||52-Week Range
10.59
-10.27%
Year-to-Date
No recent news for Recro Pharma Inc.

Today’s Trading

Previous close8.70
Today’s open8.66
Day’s range8.29 - 8.90
Volume166,435
Average volume (3 months)112,124
Market cap$158.8M
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-1,442.86%
Earnings growth (this year)+18.53%
Earnings growth (next 5 years)--
Revenue growth (last year)+33.46%
P/E ratioNM
Price/Sales1.25
Price/Book2.21

Competitors

 Today’s
change
Today’s
% change
TRVNTrevena Inc-0.00-0.30%
VCELVericel Corp-0.25-3.33%
CDMOAvid Bioservices Inc+0.12+5.06%
RDHLRedhill Biopharma Lt...+0.19+3.20%
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateMarch 6, 2018
EPS forecast (this quarter)-$0.93
Annual revenue (last year)$69.3M
Annual profit (last year)-$30.2M
Net profit margin-43.56%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gerri Henwood
Chief Operating Officer
Michael Celano
Corporate headquarters
Malvern, Pennsylvania

Forecasts